AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

ADALIMUMAB

12 registrations across 6 African markets— 10 active

Markets with ADALIMUMAB

🇿🇦South Africa
5 registrations
4 active
🇲🇦Morocco
2 registrations
2 active
🇿🇼Zimbabwe
2 registrations
2 active
🇰🇪Kenya
1 registration
1 active
🇹🇳Tunisia
1 registration
0 active
🇹🇿Tanzania
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
PAMERA 40
Solution For Injection In Pre-Filled Syringe
🇰🇪KenyaM/s. Hetero Biopharma LimitedactiveApr 2031
HYDIMOZ 40 mg/,8 ml🇿🇦South AfricaSandoz South Africa (Pty) LtdactiveOct 2029
ADALIMUMAB 40 mg/0,8 ml FRESENIUS🇿🇦South AfricaFresenius Kabi South Africa (Pty) LtdactiveJun 2029
RUMIO 40🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 2029
RUMIO 80🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 2029
HULIO (1ML)
SOLUTION
🇿🇼ZimbabweMYLAN PHARMACEUTICALS PVT LTDactiveDec 2027
HULIO (0.8ML)
SOLUTION
🇿🇼ZimbabweMYLAN PHARMACEUTICALS PVT LTDactiveDec 2027
HUMIRA 40 mg🇿🇦South AfricaAbbvie (Pty) LtdsuspendedDec 2021
HUMIRA
Solution injectable / 40 mg
🇹🇳TunisiaABBVIE DEUTSCHLAND Gmbh and Co.KGexpiredOct 2021
HUMIRA 40MG
SOLUTION INJECTABLE
🇲🇦Morocco—active—
PAMERA
Injection
🇹🇿TanzaniaHETERO BIOPHARMA LIMITEDactive—
HUMIRA 40MG
SOLUTION INJECTABLE
🇲🇦Morocco—active—

ADALIMUMAB in Africa — Regulatory Overview

ADALIMUMAB is registered across 6 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Morocco, Zimbabwe, Kenya and 2 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 10 (83%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.